HANOI, VIETNAM – Media OutReach Newswire – 14 April 2025 – The Center of Allergy and Clinical Immunology under the Vinmec Healthcare System has officially been chosen as a World Allergy Organization (WAO) Center of Excellence (CoE) — making it the first medical facility in Vietnam to receive this prestigious recognition. This milestone marks a significant advancement in the nation’s allergy and clinical immunology, aligning Vietnamese healthcare with international standards.
Vinmec Times City’s Immunology – Allergy Center named WAO Center of Excellence
WAO is a preeminent medical institution in the field of allergy and clinical immunology, comprising 115 national and regional member societies across six continents. The WAO COE are distinguished medical facilities recognized for their outstanding achievements in medical practices, education, research, innovation, and international influences.
Following a rigorous multi-stage assessment process — including credentials review, scientific evidence review, and examination of on-site operational capability — Vinmec’s Allergy and Clinical Immunology Center met WAO’s stringent criteria to earn the COE designation. This international recognition not only affirms Vinmec’s expertise in the field but also grants the Center prioritized access to international research collaborations, advanced training and clinical trials, and state-of-the-art treatment modalities through WAO and its global network of leading academic partners.
Assoc. Prof. Dr. Nguyen Van Dinh, Director of the Clinical Allergy and Immunology Center at Vinmec, commented: “Being recognized as a WAO Center of Excellence is a landmark achievement for Vietnam’s allergy and clinical immunology. This recognition enables our clinicians and researchers to gain a better understanding of advancements in allergic diagnosis and treatment, participate in research collaborations, and have access to advanced therapies of the world. It also gives our health professionals an opportunity to receive training and capacity building by world-renowned experts, thus delivering the most optimizedand personalized treatments that ensure the safety of patients”.
Prior to the CoE recognition by WAO, Vinmec’s Allergy and Clinical Immunology Center had been the first medical facility in Vietnam to receive dual recognitions in specialized allergy care, including: ADCARE (Atopic Dermatitis Centers of Reference and Excellence) and UCARE (Urticaria Centers of Reference and Excellence).
Vinmec’s Allergy and Clinical Immunology Center is also the first and only healthcare provider in Vietnam licensed by the Ministry of Health to deploy biologic therapies and advanced immunological treatments for severe chronic allergic and immunological disorders — such as bronchial asthma, atopic dermatitis, chronic urticaria, allergic rhinosinusitis with nasal polyps and prurigo nodularis.
Vietnam joins the WAO Centers of Excellence global map
Vinmec is currently at the forefront of utilizing genetic testing to screen for drug hypersensitivity risks — thereby personalizing the clinical pathway and enhancing patient safety — and applying monoclonal antibody therapies, a cutting-edge and specialized treatment modality typically available only at leading international medical institutions. Additionally, Vinmec has developed comprehensive diagnostic and management protocols for primary immunodeficiency disorders, offering patients early detection, appropriate intervention, and long-term care.
Vinmec now stands among other prestigious WAO Centers of Excellence in the region, including the National University of Singapore, Yonsei University College of Medicine (South Korea), University of Tokyo Hospital (Japan), and Shanghai Jiao Tong University School of Medicine (China).
The WAO’s recognition follows Vinmec’s previous establishment of three internationally accredited Centers of Excellence in Cardiology, Oncology, and Orthopedics & Sports Medicine. These achievements reflect Vinmec’s strategic commitment to building globally recognized centers of excellence that deliver innovative, world-class healthcare solutions to Vietnamese and international patients alike.
Coalition to focus on creating a benchmark for
how local businesses work, travel and convene in the wake of the COVID-19
pandemic
This is the third of several regional
coalitions that Aon will be rolling out globally
SINGAPORE
– Media
OutReach – 4
September 2020 – Aon
plc
(NYSE: AON), a leading global professional services firm providing a broad
range of risk, retirement and health solutions, today announced the formation
of a coalition of leading Singapore companies to strengthen communities and
move toward societal and economic recovery in the wake of the COVID-19
pandemic.
The coalition, which recently held its virtual kickoff
meeting, consists of key employers from a broad set of sectors focused on re-introducing
fundamental aspects of society and the economy: working, traveling and
convening. These top Singapore organisations will collaborate to outline a set
of guidelines for businesses and communities to help restart the economy safely.
Aon has launched similar coalitions in Chicago and New York
and plans to conduct similar efforts in other cities, including London and
Tokyo.
“We are deeply committed to the communities we operate in
and are excited to bring this important work to Singapore,” said Greg Case, Aon
CEO. “We have helped our clients maintain their operations and mitigate risk
during the pandemic and believe that we have a responsibility to play a larger
role in helping organisations return to the workplace and rebuild economies
with confidence and certainty.”
Convened and led by Aon, the coalition will focus on Work,
Travel and Convene efforts across leading businesses.
Na Boon Chong, Managing Director & Partner, Human Capital
Solutions, Southeast Asia, Aon said, “There is much to gain from a united approach,
and we welcome the partnership and sharing of expertise among Singapore
companies in navigating the pandemic. We are confident that with our
collaborative efforts, we can help local business leaders make better decisions
about protecting communities in the short term and rebuilding how we work,
travel and convene over the long term.”
Alexis Saussinan, Global Head of Strategic Workforce
Planning and Analytics, Merck said, “Bringing together companies across sectors
and top leaders across functions in Singapore is a great opportunity to share
experiences and co-create new approaches to operate and compete. I look forward
to sharing how Merck is shaping our future ways of working and learn from best
practices in other companies.”
The coalition will share insights and learnings from its ongoing
efforts across industries, sectors and geographies as well as discuss issues
related to the current pandemic. This collective knowledge will then be used to
create a first-of-its-kind benchmark to develop recommendations and guidelines
to build a path forward. Aon expects to publish an initial assessment report in
November 2020.
About Aon
Aon plc (NYSE: AON) is a
leading global professional services firm providing a broad range of risk,
retirement and health solutions. Our 50,000 colleagues in 120 countries empower
results for clients by using proprietary data and analytics to deliver insights
that reduce volatility and improve performance.
https://www.vinmec.com/eng/
Twitter
LinkedIn